This site is intended for healthcare professionals only
LoginRegister
Lupin receives USFDA observations for two Pithampur manufacturing UnitsLupin Gets CDSCO Panel Nod to Study Antidiabetic FDC
Novartis, Argo Biopharma expand strategic alliance with USD 5.2 billion Cardiovascular drugs dealCDSCO Panel Approves Novartis's Protocol Amendment Proposal to Study Ianalumab
Hetero Biopharma Gets CDSCO Panel Nod for Phase IV Trial of Denosumab Injection in Cancer PatientsHetero Labs Gets CDSCO Panel Nod to Study Vonoprazan Tablet
Sanofi gets USFDA fast track designation for neovascular age-related macular degeneration gene therapyCDSCO panel approves Sanofi Healthcare's protocol amendment proposal to study SAR441566
Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug MacitentanIndoco Remedies Varenicline Tablets gets USFDA nod to aid smoking cessation treatment
Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag InternationalJohnson and Johnson gets European Commission nod for expanded use of HIV 1 therapy Edurant in...
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIAIQVIA Gets CDSCO Panel Nod to Study KarXT in Schizophrenia
Sanofi gets USFDA fast track designation for neovascular age-related macular degeneration gene therapySanofi gets CDSCO Panel nod to study Amlitelimab
CDSCO Panel Rejects Theon Pharmas Proposal for Empagliflozin, Linagliptin, Metformin FDCLa Renon's plea to exempt Sodium Valproate from NPPA price cap rejected
CDSCO Panel Clears Abbotts Phase IV Trial for Empagliflozin + Metformin FDC, Seeks More SitesAbbott initiates new clinical trial to improve outcomes in patients with advanced Heart Failure
AstraZeneca announces Rs 176 crore investments in India to expand Chennai GITCAstraZeneca Fasenra approved in the EU for eosinophilic granulomatosis with polyangiitis
Novartis to buy Tourmaline Bio for USD 1.4 billionMerck acquires cancer therapy developer Modifi Biosciences
X